Coming from a background of analytical chemistry, my research has focused on developing vibrational spectroscopic techniques to address a wide range of bioanalytical problems spanning the clinical and biological fields. Clinical Spectroscopy is a multidisciplinary field that involves research in chemistry, optics, and statistics to provide applications in the biomedical context. I have been very lucky to work in different labs across Europe and Australia, including France (1.5 years), Germany (0.5 years), Australia (4.5 years) and Ireland (2 years). I have finally settled in the University of Valencia with a Ramon y Cajal grant, where I am establishing myself as an independent researcher.

 My contribution to the field of vibrational spectroscopy has advanced knowledge in 4 central themes:
i) Sample processing for IR analysis: Improving clinical spectroscopy methods by using sample pretreatment techniques. 
ii) Chemometrics and data fusion: Application of novel chemometric datamining algorithms. Development of methods for fusing data from different modalities, including infrared (IR) and Mass Spectrometry and the multimodal imaging of IR and Raman.
ii) Infrared and Raman micro- and nano- imaging. Images of cells and tissues using Raman and IR. Use of Atomic Force Microscope (AFM) coupled with IR and Tip Enhanced Raman Spectroscopy (TERS).
iv) Translational research. Development of methods for biofluid analysis, and most notably diagnosis of Malaria in developing countries and quantification of clinical parameters for bio-fluids at the hospital level and in the point-of-care context. Field trials in Thailand using portable instrumentation.

Scientific Output:  I have authored more than 60 journal articles and 2 chapters in indexed scientific journals: 55% as the first or corresponding author, 66% of the articles published in the first Quartile (Q1) of their respective field. These works have been cited 1200 times (Jan,2020); h-index is 23; [Google Scholar] and I obtained a granted US patent. As a PI, my projects have obtained more than 500K EUR in funding from institutions in Europe, Australia and Asia.

Dr Torres-Pérez (he/him) is a neurobiologist interested in the epigenetic landscape regulating neural development and its impact on neurodegenerative disorders. Dr Torres-Pérez currently holds a Ramón y Cajal contract at the University of Valencia, where he leads an independent research program on the epigenetic mechanisms underlying pain and sociability-related disorders, using both rodent and zebrafish (Danio rerio) models. He has been successfully involved in a wide range of multi-disciplinary projects spanning from clinical settings to academic scenarios with engineers/materials scientists and experimental psychologists.

Dr Torres-Pérez gained his undergraduate degree in Biology at the University of Valencia (UV) and then moved to Oxford for a 6-month internship at the Wellcome Trust Centre for Human Genetics. After that, Dr Torres-Pérez completed an MRes in Neuroscience at the Autonomous University of Barcelona. For his PhD in Clinical Medicine Research, Dr Torres-Pérez worked with Dr Istvan Nagy at the Chelsea and Westminster Hospital, Imperial College London. He investigated the role different epigenetic tags, mainly histone post-translational modifications, play in the transition from acute to chronic pain at neurons and glial cells of both spinal cord and dorsal root ganglia.

Dr Torres-Pérez has held two postdoctoral positions at Queen Mary University of London. First at the School of Engineering and Materials Science, where he performed high-resolution electrophysiology of primary cilia and single-cell calcium recordings. Secondly, at the School of Biological and Chemical Sciences, where he used zebrafish as a reverse genetic model for comparative cognition.

Right after, he moved to the UK Dementia Research Institute at Imperial College London (White City Campus) for a Research Associate position in Epigenetics. There, Dr Torres-Pérez obtimised an adapted version of CUT&RUN (Cleavage Under Targets and Release Using Nuclease) tailored for the processing of human brain samples.

He joined the University of Valencia (UV) as a distinguished researcher under the APOST (Generalitat Valenciana) and then under a María Zambrano program (Ministry of Universities, Spain) before obtaining his Ramón y Cajal. His recent achievements include high-impact publications as first and senior author, the successful coordination of international collaborations, and invitations to speak at national and international neuroscience conferences.